English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In 2014, approximately 75,000 new cases of bladder cancer diagnosed in the USA [1]. Urological cancers account for about 14 % of cancers diagnosed globally and more than a fifth of all cancers in Europe [2]. Bladder cancer is the fourth-most frequent one in males after prostate, lung, and colon cancers [3]. The second most malignancy of genitourinary system is bladder cancer, with male-tofemale ratio of 3.8:1 [4,5].

The Effect of Blood Groups and Rhesus Factor on Prognosis and Survival in Bladder Cancer Patients Underwent Radical Cystectomy